|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> ABT 472>> Market Analysis Reports |
Market Analysis Reports of ABT 472 |
|
Therapy Class Overview : Hepatitis C Virus Infection ... (PhIII) and AbbVie/ Enanta’s (ABT-450r/ABT-472/ABT-333) should remove the need ... Therapeutic Class Report Overview : Hepatitis C Virus Infection The launch of Protease inhibitors’ (PIs) created a wave in 2011-12 and accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations have raised the bar and the expectations of pts, physicians ... |